Phase II trial of dovitinib in recurrent glioblastoma.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of dovitinib in recurrent glioblastoma.

Published:2015-05-20 Issue:15_suppl Volume:33 Page:2050-2050
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ahluwalia Manmeet Singh¹,Papadantonakis Nikolaos¹,Alva Venur Vyshak²,Schilero Cathy¹,Peereboom David M.³,Stevens Glen⁴,Rosenfeld Steven¹,Vogelbaum Michael A.⁵,Elson Paul¹,Nixon Andrew B.⁶,McCrae Keith¹

Affiliation:

1. Cleveland Clinic, Cleveland, OH

2. Fairview Hospital, Cleveland Clinic, Cleveland, OH

3. Cleveland Clinic Fndtn Desk, Cleveland, OH

4. Cleveland Clinic Foundation, Cleveland, OH

5. Cleveland Clinic Brain Tumor I, Cleveland, OH

6. Duke University Medical Center, Durham, NC

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.15_suppl.2050

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma;Pharmaceuticals;2024-07-23

2. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery;Pharmaceutics;2022-12-24

3. Anti-angiogenic therapies in the management of glioblastoma;Chinese Clinical Oncology;2021-08

4. Current Challenges and Opportunities in Treating Glioblastoma;Pharmacological Reviews;2018-04-18

5. Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer;Journal of Medicinal Chemistry;2016-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP